Alshimary NAAH, Tweij T-AR. Praliciguat alleviates ferroptosis and inflammation in renal ischemia/reperfusion injury by targeting the AMPK/ACC/PUFA pathway. Babcock Univ. Med. J. [Internet]. 2025 Dec. 31 [cited 2026 Nov. 8];8(2):198-207. Available from: https://bumj.babcock.edu.ng/index.php/bumj/article/view/992